SequelSEC

Longevity Health Holdings, Inc. XAGE

Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics · CIK 0001842939 · Fiscal year ends 1231

Revenue
$1.69M
Fiscal year ended 2026-06-30
Operating income
-$5.79M
Fiscal year ended 2026-06-30
Free cash flow
Unavailable
Fiscal year ended 2026-06-30

Longevity Health Holdings, Inc. (XAGE) reported revenue of $1.69M and net income of -$6.83M for the fiscal year ended 2026-06-30. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from Longevity Health Holdings, Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics.

Income

Longevity Health Holdings, Inc. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Revenue$1.69M
Cost of revenue$691.76K
Gross profit$994.84K
Operating income-$5.79M
Net income-$6.83M
Research & development$460.91K
Weighted-average diluted sharesUnavailable
Pretax income-$6.79M
Income tax expense$36.26K
Diluted EPSUnavailable
Selling, general & administrativeUnavailable
General & administrativeUnavailable
Selling & marketing$1.16M

Balance

Longevity Health Holdings, Inc. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Cash & equivalents$35.47K
Total assets$1.06M
Current assets$711.72K
Total liabilities$9.75M
Current liabilities$9.59M
Total equity incl. NCI-$8.70M
Temporary (mezzanine) equityUnavailable
Inventory$606.67K
Accounts receivable$19.55K
GoodwillUnavailable
Long-term debtUnavailable
Accounts payable$5.04M

Cash flow

Longevity Health Holdings, Inc. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Operating cash flow-$2.45M
Capital expendituresUnavailable
Investing cash flowUnavailable
Financing cash flow$932.79K
Net change in cashUnavailable
Stock-based compensation$608.32K
Common dividends paidUnavailable
Common share repurchasesUnavailable
Depreciation & amortization$60.92K

Derived

Longevity Health Holdings, Inc. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Free cash flowUnavailable
Gross margin59.0%
Operating margin-343.6%
FCF marginUnavailable
SBC / revenue36.1%
Current ratio0.07x
Revenue YoY growth60.3%
Net margin-404.8%
R&D / revenue27.3%
CapEx / revenueUnavailable
Long-term debt / equityUnavailable
Effective tax rateUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open XAGE in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-14View SEC filing
10-Q · Filed 2026-05-15View SEC filing
10-K · Filed 2026-03-31View SEC filing
10-Q · Filed 2025-11-14View SEC filing
10-Q · Filed 2025-08-14View SEC filing
10-K/A · Filed 2025-06-17View SEC filing

Companies in the same industry

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.